The Current Ratio as of September 2024 (TTM) for Kiromic BioPharma, Inc. (KRBP) is 0.35

According to Kiromic BioPharma, Inc.’s latest financial reports and current stock price. The company's current Current Ratio is 0.35. This represents a change of 17.90% compared to the average of 0.30 of the last 4 quarters.

Kiromic BioPharma, Inc. (KRBP) Historical Current Ratio (quarterly & annually)

How has KRBP Current Ratio performed in the past?

The mean historical Current Ratio of Kiromic BioPharma, Inc. over the last ten years is 3.26. The current 0.35 Current Ratio has changed 984.61% with respect to the historical average. Over the past ten years (40 quarters), KRBP's Current Ratio was at its highest in in the September 2021 quarter at 24.86. The Current Ratio was at its lowest in in the June 2001 quarter at 0.

Kiromic BioPharma, Inc. (KRBP) Current Ratio by Quarter and Year

Discovering the peaks and valleys of Kiromic BioPharma, Inc. Current Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kiromic BioPharma, Inc. (KRBP) Average Current Ratio

How has KRBP Current Ratio performed in the past?

The current Current Ratio of Kiromic BioPharma, Inc. (KRBP) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kiromic BioPharma, Inc. (KRBP) Current Ratio vs. Peers

How is KRBP’s Current Ratio compared to its peers?

Kiromic BioPharma, Inc.’s Current Ratio is less than Quoin Pharmaceuticals, Ltd. (3.35), less than Allarity Therapeutics, Inc. (2.01), less than Virax Biolabs Group Limited (25.94), less than Biodexa Pharmaceuticals Plc (1.26), less than Zura Bio Limited (12.57), less than Altamira Therapeutics Ltd. (1.38), less than Immix Biopharma, Inc. (7.00), less than Enveric Biosciences, Inc. (7.37), less than Palisade Bio, Inc. (4.31), greater than CNS Pharmaceuticals, Inc. (0.31), less than eFFECTOR Therapeutics, Inc. (1.03), less than Navidea Biopharmaceuticals, Inc. (0.56), less than Sonnet BioTherapeutics Holdings, Inc. (1.65), less than Sigilon Therapeutics, Inc. (1.78), less than Reviva Pharmaceuticals Holdings, Inc. (0.41), greater than ZyVersa Therapeutics, Inc. (0.06), less than Unicycive Therapeutics, Inc. (3.37),

Build a custom stock screener for Kiromic BioPharma, Inc. (KRBP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kiromic BioPharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kiromic BioPharma, Inc. (KRBP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kiromic BioPharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.